When was Simergent founded?

Simergent was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Simergent located?

Simergent is headquartered in Chicago, United States.

How many employees does Simergent have?

As of Aug 31, 2026, the latest employee count at Simergent is 6.

Is Simergent a funded company?

Simergent is a funded company, having raised a total of $13M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 18, 2017.

When was the latest funding round of Simergent?

Simergent's latest funding was a $***** Grant (prize money) round on Dec 11, 2025, with participation from 1 investor. Its primary sector is Nephrology. In United States, the Nephrology sector has seen $165M in funding in 2026 to date.

Where does Simergent rank among its competitors?

Simergent ranks 1st amongst 15 active competitors, of which 7 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Simergent, which secured $1.67M in Dec, 2025.

Who are the top competitors of Simergent?

Simergent's top competitors include Opterion, Vivance and TrioMed. Among them, Simergent secured the most recent funding round in December, 2025.

Simergent - 2026 Company Profile, Team, Funding & Competitors

Simergent is a series A company based in Chicago (United States), founded in 2014 by Steve Lindo and Rick Pendergraft. It operates as a Manufacturer of automated peritoneal dialysis system. Simergent has raised $13M in funding from i2E. The company has 15 active competitors, including 7 that are funded. Its top competitors include companies like Opterion, Vivance and TrioMed.

Company Details

Simergent is developing automated peritoneal dialysis devices which can be used at home. The dialysis has applications in end-stage renal disease. They export their products to Mexico, China, India, and others.

Website: www.simergent.com/
Social
Email ID: *****@simergent.com

Key Metrics

Founded Year

2014

Location

Chicago, United States

Stage

Series A

Total Funding

$13M in 5 rounds

Latest Funding Round

Grant (prize money), Dec 11, 2025, $*****

Investors

i2E & 4 more

Ranked

1^st among 15 active competitors

Employee Count

6 as on Aug 31, 2026

Similar Companies

Opterion & 15 more

View Simergent's full profile

Simergent has raised a total funding of $13M over 5 rounds. Its first funding round was on Apr 18, 2017. Its latest funding round was a Grant (prize money) round on Dec 11, 2025 for $*****. 1 investor participated in its latest round. Simergent has 5 institutional investors.

Here is the list of recent funding rounds of Simergent:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 11, 2025	1704851	Grant (prize money)	3688316	2593646	6484277	9618799
Mar 29, 2024	2947412	Series A	5528080	3062971	8239512	1098197
Oct 25, 2017	3904952	Seed	6490105	9280471	i2E	1110223

Access funding benchmarks and valuations. Sign up today!

View details of Simergent's funding rounds and investors

The founders of Simergent are Steve Lindo and Rick Pendergraft.

Here are the details of Simergent's key team members:

Steve Lindo: Co-Founder & CEO of Simergent.
Rick Pendergraft: Co-Founder of Simergent.
Contact Info: 1 email address

View details of Simergent's Founder profiles and Board Members

Simergent's employee count trend

Simergent has 6 employees as of Aug 26. Here is Simergent's employee count trend over the years:

Uncover Simergent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Simergent include Opterion, Vivance and TrioMed. Here is the list of Top 10 competitors of Simergent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Simergent 2014, Chicago (United States), Series A	Manufacturer of automated peritoneal dialysis system	$13M	MTT Ventures, Plains Ventures & 3 others	52/100
2nd	Opterion 2012, Sarnen (Switzerland), Series B	Developer of therapeutic solutions for the treatment of acute kidney diseases	$17.4M	Hemex, HEMEX	51/100
3rd	Vivance 2010, Magog (Canada), Series B	Do Not Publish request by OD	$71.2M	Vickers Venture Partners, Lion X Ventures ... & 4 others	41/100
4th	TrioMed 2005, Lund (Sweden), Series A	Developer of peritoneal dialysis system designed to improve treatment and outcomes	-	Almi Invest, KMG Capital Partners & 1 others	41/100
5th	Mitra Industries 1995, Faridabad (India), Unfunded	Developer of noncardiac stents and blood bags	-	-	39/100
6th	liberDi 2014, Or Akiva (Israel), Seed	Portable peritoneal dialysis systems for renal disorders	$1.13M	Intuition Fund, The Trendlines Group & 4 others	36/100
7th	Avyantra 2017, Hyderabad (India), Funding Raised	Developer of ML technology for neonatal diseases and automated peritoneal dialysis device	-	C-CAMP, BIRAC & 4 others	33/100
8th	Relavo 2020, Baltimore (United States), Funding Raised	Developer of dialysis devices for kidney failure patients	-	Pipeline Angels, Springboard Enterprises & 3 others	30/100
9th	Padmaseetha Technologies 2014, Chennai (India), Seed	Developer of connected devices for renal dialysis	-	CIE IIITH, RTBI & 6 others	30/100
10th	GlomeriaTherapeutics 2010, Chieti (Italy), Series A	Developing devices for treatment of nephropathy and cardiopathy	$1.13M	EIC Fund, Sofimac Investment Managers & 3 others	27/100